High field (9.4 Tesla) magnetic resonance imaging of cortical grey matter lesions in multiple sclerosis.

Multiple sclerosis is an inflammatory, degenerative disease of the central nervous system. The most obvious pathological change in multiple sclerosis is multifocal demyelination of the white matter, but grey matter demyelination may be of equal or even greater importance for its clinical manifestations. In order to assess the pathogenetic role of lesions in the grey and white matter, and to explore the association between demyelinated and non-lesional brain tissue, tools are needed to depict each of these tissue components accurately in vivo. Due to its sensitivity in detecting white matter lesions, T(2)-weighted magnetic resonance imaging at 1.5 T is important in the diagnosis of multiple sclerosis. However, magnetic resonance imaging at 1.5 T largely fails to detect grey matter lesions. In this study, we used T(2)-weighted magnetic resonance imaging at 9.4 T to detect grey matter lesions in fixed post-mortem multiple sclerosis motor cortex. Furthermore, we produced T(1), T(2) and magnetization transfer ratio maps, and correlated these indices with quantitative histology [neuronal density, intensity of immunostaining for myelin basic protein (reflecting myelin content) and phosphorylated neurofilament (reflecting axonal area)] using t-tests and multivariate regression. In 21 tissue samples, 28 cortical grey matter lesions were visible on both T(2)-weighted magnetic resonance imaging and sections immunostained for myelin basic protein, 15/28 being mixed white and grey matter and 11/28 subpial cortical grey matter lesions; 2/28 cortical grey matter lesions involved all layers of the cortex. Compared with non-lesional cortex, cortical grey matter lesions showed reduction of neuronal density (98/mm(2), SD = 34/mm(2;) versus 129/mm(2), SD = 44; P < 0.01), phosphorylated neurofilament (1/transmittance = 1.16; SD = 0.09 versus 1.24; SD = 0.1; P < 0.01) and magnetization transfer ratio (31.1 pu; SD = 11.9 versus 37.5 pu; SD = 8.7; P = 0.01), and an increase of T(2) (25.9; SD = 5 versus 22.6 ms; SD = 4.7; P < 0.01). Associations were detected between phosphorylated neurofilament and myelin basic protein (r = 0.58, P < 0.01), myelin basic protein and T(2) (r = -0.59, P < 0.01), and neuronal density and T(1) (r = -0.57, P < 0.01). All indices correlated with duration of tissue fixation, however, including the latter in the analysis did not fundamentally affect the associations described. Our data show that T(2)-weighted magnetic resonance imaging at 9.4 T enables detection of cortical grey matter lesion in post-mortem multiple sclerosis brain. The quantitative associations suggest that in cortical grey matter T(1) may be a predictor of neuronal density, and T(2) of myelin content (and-secondarily-axons). Successful translation of these results into in vivo studies using high field magnetic resonance imaging (e.g. 3 T and 7 T) will improve the assessment of cortical pathology and thereby have an impact on the diagnosis and natural history studies of patients with multiple sclerosis, as well as clinical trial designs for putative treatments to prevent cortical demyelination and neuronal loss.

[1]  D. Chard,et al.  Grey matter pathology in clinically early multiple sclerosis: Evidence from magnetic resonance imaging , 2009, Journal of the Neurological Sciences.

[2]  Penny A. Gowland,et al.  T1: The Longitudinal Relaxation Time , 2004 .

[3]  A. Boyde,et al.  Unbiased estimation of particle density in the tandem scanning reflected light microscope , 1985, Journal of microscopy.

[4]  R. Reynolds,et al.  Normal-appearing white matter in multiple sclerosis is in a subtle balance between inflammation and neuroprotection. , 2007, Brain : a journal of neurology.

[5]  J. Dawson,et al.  The Histology of Disseminated Sclerosis , 1916, Edinburgh Medical Journal.

[6]  B. Trapp,et al.  Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions , 2001, Annals of neurology.

[7]  B. Trapp,et al.  Subpial Demyelination in the Cerebral Cortex of Multiple Sclerosis Patients , 2003, Journal of neuropathology and experimental neurology.

[8]  S. Deoni,et al.  High‐resolution T1 mapping of the brain at 3T with driven equilibrium single pulse observation of T1 with high‐speed incorporation of RF field inhomogeneities (DESPOT1‐HIFI) , 2007, Journal of magnetic resonance imaging : JMRI.

[9]  M. Maier Quantitative MRI of the brain—measuring changes caused by disease , 2004 .

[10]  H. D. de Vries,et al.  The Blood-Brain Barrier in Cortical Multiple Sclerosis Lesions , 2007, Journal of neuropathology and experimental neurology.

[11]  G. Moore MRI-clinical correlations: more than inflammation alone-what can MRI contribute to improve the understanding of pathological processes in MS? , 2003, Journal of the Neurological Sciences.

[12]  G. Barker,et al.  An interleaved sequence for accurate and reproducible clinical measurement of magnetization transfer ratio. , 1996, Magnetic resonance imaging.

[13]  Peter K. Stys,et al.  Gray matter pathology in (chronic) MS: Modern views on an early observation , 2009, Journal of the Neurological Sciences.

[14]  A. Compston,et al.  Multiple sclerosis. , 2002, Lancet.

[15]  H J Gundersen,et al.  The efficiency of systematic sampling in stereology and its prediction * , 1987, Journal of microscopy.

[16]  B D Trapp,et al.  Intracortical multiple sclerosis lesions are not associated with increased lymphocyte infiltration , 2003, Multiple sclerosis.

[17]  Hans Lassmann,et al.  Cortical demyelination and diffuse white matter injury in multiple sclerosis. , 2005, Brain : a journal of neurology.

[18]  David H. Miller,et al.  Quantitative magnetic resonance of postmortem multiple sclerosis brain before and after fixation , 2008, Magnetic resonance in medicine.

[19]  F. Barkhof,et al.  Does high-field MR imaging improve cortical lesion detection in multiple sclerosis? , 2008, Journal of Neurology.

[20]  Hans Lassmann,et al.  Widespread Demyelination in the Cerebellar Cortex in Multiple Sclerosis , 2007, Brain pathology.

[21]  B. Brownell,et al.  The distribution of plaques in the cerebrum in multiple sclerosis , 1962, Journal of neurology, neurosurgery, and psychiatry.

[22]  S. Reingold,et al.  Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria” , 2005, Annals of neurology.

[23]  P. Matthews,et al.  Neocortical neuronal, synaptic, and glial loss in multiple sclerosis , 2006, Neurology.

[24]  J. Geurts,et al.  Grey matter pathology in multiple sclerosis , 2006, Acta neurologica Scandinavica. Supplementum.

[25]  A. Thompson,et al.  Disability and T2 MRI lesions: a 20-year follow-up of patients with relapse onset of multiple sclerosis. , 2008, Brain : a journal of neurology.

[26]  O. Kantarci,et al.  Gray Matter Atrophy Is Related to Long-Term Disability in Multiple Sclerosis , 2009 .

[27]  M. Schlamann,et al.  First Clinical Study on Ultra-High-Field MR Imaging in Patients with Multiple Sclerosis: Comparison of 1.5T and 7T , 2009, American Journal of Neuroradiology.

[28]  T. Peters,et al.  High‐resolution T1 and T2 mapping of the brain in a clinically acceptable time with DESPOT1 and DESPOT2 , 2005, Magnetic resonance in medicine.

[29]  A. Thompson,et al.  Magnetization transfer ratio abnormalities reflect clinically relevant grey matter damage in multiple sclerosis , 2009, Multiple sclerosis.

[30]  B. Pakkenberg,et al.  Neocortical glial cell numbers in human brains , 2008, Neurobiology of Aging.

[31]  Frederik Barkhof,et al.  Grey matter pathology in multiple sclerosis , 2008, The Lancet Neurology.

[32]  Caterina Mainero,et al.  In vivo imaging of cortical pathology in multiple sclerosis using ultra-high field MRI , 2009, Neurology.

[33]  J. Wolinsky,et al.  3D MPRAGE improves classification of cortical lesions in multiple sclerosis , 2008, Multiple sclerosis.

[34]  Frederik Barkhof,et al.  Cortical lesions in multiple sclerosis: combined postmortem MR imaging and histopathology. , 2005, AJNR. American journal of neuroradiology.

[35]  D. Chard,et al.  Is multiple sclerosis a generalized disease of the central nervous system? An MRI perspective , 2009, Current opinion in neurology.

[36]  H. Merkle,et al.  Multisequence-imaging protocols to detect cortical lesions of patients with multiple sclerosis: Observations from a post-mortem 3 Tesla imaging study , 2009, Journal of the Neurological Sciences.

[37]  A. Kangarlu,et al.  Cerebral cortical lesions in multiple sclerosis detected by MR imaging at 8 Tesla. , 2007, AJNR. American journal of neuroradiology.

[38]  C. Poser,et al.  Diagnostic criteria for multiple sclerosis , 2001, Clinical Neurology and Neurosurgery.

[39]  Cortical plaques visualised by fluid-attenuated inversion recovery imaging in relapsing multiple sclerosis , 1996, Neuroradiology.

[40]  Christine Stadelmann,et al.  Extensive Cortical Remyelination in Patients with Chronic Multiple Sclerosis , 2007, Brain pathology.

[41]  J. Winn,et al.  Brain , 1878, The Lancet.

[42]  Frederik Barkhof,et al.  Intracortical lesions in multiple sclerosis: improved detection with 3D double inversion-recovery MR imaging. , 2005, Radiology.

[43]  P. Tofts Quantitative MRI of the Brain , 2003 .

[44]  David H. Miller,et al.  Magnetization transfer ratio and myelin in postmortem multiple sclerosis brain , 2004, Annals of neurology.

[45]  J. Dawson,et al.  XVIII.–The Histology of Disseminated Sclerosis , 1916, Transactions of the Royal Society of Edinburgh.